The largest database of trusted experimental protocols

Stata se version 14.1 statistical software

Manufactured by StataCorp

STATA/SE version 14.1 is a statistical software package developed by StataCorp. It is designed for data analysis, management, and visualization. The software provides a wide range of statistical tools and techniques for various types of data analysis.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using stata se version 14.1 statistical software

1

Predictors of Relapse in Hematological Malignancies

Check if the same lab product or an alternative is used in the 5 most similar protocols
A univariate logistic regression model was used to analyze the association between MRD negativity and factors potentially predicting relapse. Relapse-free survival (RFS) was measured from the date of CR until relapse. Patients without relapse at their last follow-up monitoring were censored on that date. The Kaplan-Meier method was used to estimate the median RFS. Univariate Cox proportional hazards regression was performed to identify the association between each of the variables and RFS. Multivariate Cox proportional hazards regression was used to model all the variables in the univariate setting. The backward selection method was used to remove variables that did not remain significant in the multivariate model (p=0.15). Hazard ratios (HRs) were generated with 95% confidence intervals (95% CI). Data were analyzed with STATA/SE version 14.1 statistical software (Stata Corp. LP, College Station, TX). The Student t-test was used to analyze the statistical significance of differences between groups, both in vitro and in vivo. All statistical tests were two-sided, and the results are expressed as the mean ± standard deviation. A p value ≤ 0.05 was considered statistically significant.
+ Open protocol
+ Expand
2

Anthropometric Changes and Survival in PD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anthropometric and nutritional parameters were measured upon presentation, prior to PD, and approximately 3 and 12 months after surgery. Differences compared to baseline were first assessed using paired t-tests. These comparisons only test for differences in the setting of complete data, which were not available for all patients. In order to control for missing data, changes over time for each anthropometric and nutritional parameter were also analyzed utilizing a multilevel mixed-effects linear regression model, which takes into account correlations between measurements and fixed effects. Beta coefficients (B) and 95% confidence intervals (CIs) were calculated.
Next, univariate Cox proportional hazards regression models were created to evaluate the association between clinicopathologic and anthropometric factors and overall survival, which was calculated from the date of tissue diagnosis to the date of death. Baseline values as well as changes in anthropometrics over time, per 10 units cm2/m2, were analyzed for their potential association with survival. Hazard ratios (HR) and 95% CIs were calculated. Statistical significance was set at a two-tailed p-value <0.05. All statistical analyses were performed using Stata/SE version 14.1 statistical software (StataCorp LLC, College Station, TX).
+ Open protocol
+ Expand
3

Identifying Prognostic Factors in CML-BP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Univariate and multivariate Cox proportional hazard models were performed to identify specific characteristics of CML-BP which can predict for survival outcomes. Variables with p-value ≤0.25 in the univariate analysis were entered into a multivariate model. Median survival and survival probabilities were analyzed using the Kaplan-Meier methods and differences calculated by the log-rank test. We used classification and regression tree (CART) analysis to identify the optimal cut off points for specific parameters associated with survival, subsequently we identified prognostic factors which could independently predict survival in CML-BP. A p-value of <0.05 was considered significant. Statistical analyses were carried out using STATA/SE version 14.1 statistical software (Stata Corp. LP, College Station, Texas).
+ Open protocol
+ Expand
4

Survival Analysis of Pancreatic Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Summary statistics were used to describe the overall population and patients that developed PC. OS was calculated as the number of months from the date of diagnosis to death or lost to follow-up. Patients who were lost to follow-up were censored on that date. The Kaplan-Meier product limit method [17 ] was used to estimate the median OS. Univariate Cox proportional hazards regression was used to identify any association with each of the variables and OS [18 ]. For each factor, medians, HRs, their 95% confidence intervals (CI), and proportional hazards regression p-values were determined. Recurrence-free survival (RFS) was calculated as the number of months from the date of diagnosis to recurrence or death. Patients who were lost to follow-up were censored on that date. Similar analysis was performed for RFS. Time to occurrence of PC was calculated as the number of months from the date of diagnosis to developing PC. Patients who did not develop PC were censored on that date.
Statistical analysis was performed using STATA/SE version 14.1 statistical software (Stata Corp. LP, College Station, TX).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!